image header

News Releases

News Releases

Jan 27, 2022

ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer Read more

Jan 10, 2022

ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022 Read more

Jan 4, 2022

ALX Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference Read more

Displaying 11 - 13 of 13